Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma
Jawad Ali, Wenwen Liu, Wenzhe Duan, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 18, pp. 1130-1130
Open Access | Times Cited: 12

Showing 12 citing articles:

METTL protein family: focusing on the occurrence, progression and treatment of cancer
Huhu Zhang, Fulin Sun, Shuyao Jiang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Potential prognostic and predictive biomarkers: METTL5, METTL7A, and METTL7B expression in gastrointestinal cancers
Shirin Heydari, Maryam Peymani, Mehrdad Hashemi, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy
Xiaochuan Chen, Zhengjin Jiang, Junping Pan, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Zhipeng Jiang, Wen Yin, Hecheng Zhu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 20
Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma
Xiaochuan Chen, Chao Li, Ying Li, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 11
METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells
Rong Li, Mu Chen, Yundi Cao, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 16, pp. 895-895
Open Access | Times Cited: 8
Defining the elusive oncogenic role of the methyltransferase TMT1B
Sarah Denford, Brian T. Wilhelm
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
The prognostic signature based on glycolysis-immune related genes for acute myeloid leukemia patients
Hui Hou, Yu Wu, Junmei Guo, et al.
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152355-152355
Closed Access | Times Cited: 1
Investigation of risk signatures associated with anoikis in thyroid cancer through integrated transcriptome and Mendelian randomization analysis
Xiangyi Chen, Jingyue Lai, Wen‐Jun Shen, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Identification of immune regulatory protein coding genes in the development of lung adenocarcinom a (LUAD)
Ge Wen, Hua Tang, Jing Wang, et al.
Tropical Journal of Pharmaceutical Research (2023) Vol. 22, Iss. 3, pp. 543-552
Open Access
Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2
Xiaodong Yang, Ming Li, Zhencong Chen, et al.
Journal of Cancer (2022) Vol. 13, Iss. 5, pp. 1512-1522
Open Access
Bioinformatic analysis of methyltransferase-like protein family reveals clinical and functional outcomes in human cancer
Ion John Campeanu, Yuanyuan Jiang, Lanxin Liu, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top